Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02326272
What this trial is testing

Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 227
Testing effectiveness (Phase 2)Ended earlyNCT00782613
What this trial is testing

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Synvista Therapeutics, Inc 30
Not applicableLooking for participantsNCT04751396
What this trial is testing

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Who this might be right for
Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more
M.D. Anderson Cancer Center 125
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT02672852
What this trial is testing

BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Who this might be right for
Psoriasis
AbbVie 507
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Study completedNCT01071252
What this trial is testing

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 125
Not applicableStudy completedNCT00727298
What this trial is testing

Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)

Who this might be right for
Arthritis, RheumatoidSpondylitis, AnkylosingArthritis, Psoriatic+2 more
Merck Sharp & Dohme LLC 4,485
Large-scale testing (Phase 3)Study completedNCT04711902
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 41
Not applicableStudy completedNCT00823914
What this trial is testing

Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life

Who this might be right for
Psoriasis
Massachusetts General Hospital 116
Not applicableUnknownNCT04324866
What this trial is testing

Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy

Who this might be right for
Coronavirus Infection
Universita di Verona 300
Testing effectiveness (Phase 2)Study completedNCT01246583
What this trial is testing

CP-690-550 Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 71
Post-approval studies (Phase 4)Study completedNCT00168753
What this trial is testing

Community Based Trial for AMEVIVE®

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Astellas Pharma Inc 114
Testing effectiveness (Phase 2)Study completedNCT00678210
What this trial is testing

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 197
Large-scale testing (Phase 3)Study completedNCT02394561
What this trial is testing

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

Who this might be right for
Plaque Type Psorisis
Novartis Pharmaceuticals 434
Not applicableStudy completedNCT02786186
What this trial is testing

A Registry of Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 2,376
Large-scale testing (Phase 3)Active Not RecruitingNCT03451851
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 120
Large-scale testing (Phase 3)Study completedNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Not applicableTemporarily pausedNCT01279629
What this trial is testing

Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Glenmark Farmacêutica Ltda 50
Next Page